Due to improved tissue regeneration and the enabling of post-operative minimally invasive interventions in the same vessel segment, biodegradable polymeric scaffolds represent a competitive approach to permanent metallic stents in vascular applications. Despite these advantages some challenges, such as the improvement of the scaffold mechanics and enhancement of scaffold visibility during the implantation procedure, are persisting. Therefore, the scope of our studies was to investigate the potential of gold, silver and magnetite nanoparticles incorporated in a polymeric blend of poly(L-lactide)/poly(4-hydroxybutyrate) for image enhancement in X-ray, magnetic resonance or near-infrared imaging. Their impact on mechanical properties of such modified scaffold materials was also evaluated.
FischmanDLLeonMBBaimDS. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med1994; 331(8): 496–501.
2.
JonerMFinnAVFarbA. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol2006; 48(1): 193–202.
3.
NebekerJRVirmaniRBennettCL. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol2006; 47: 175–181.
4.
LanzerPSternbergKSchmitzKP. Drug-eluting coronary stent very late thrombosis revisited. Herz2008; 33(5): 334–342.
5.
FarooqVGogasBDSerruysPW. Restenosis: delineating the numerous causes of drug-eluting stent restenosis. Circ Cardiovasc Interv2011; 4(2): 195–205.
6.
LudererFLöblerMRohmHW. Biodegradable sirolimus-loaded poly(lactide) nanoparticles as drug delivery system for the prevention of in-stent restenosis in coronary stent application. J Biomater Appl2011; 25(8): 851–875.
7.
SternbergKKramerSNischanC. In vitro study of drug-eluting stent coatings based on poly(L-lactide) incorporating cyclosporine A - drug release, polymer degradation and mechanical integrity. J Mater Sci Mater Med2007; 18(7): 1423–1432.
8.
BüngerCMGrabowNKrögerC. Iliac anastomotic stenting with a sirolimus-eluting biodegradable poly-L-lactide stent: a preliminary study after 6 weeks. J Endovasc Ther2006; 13(5): 630–639.
OrmistonJASerruysPWRegarE. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet2008; 371(9616): 899–907.
11.
SerruysPWOrmistonJAOnumaY. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet2009; 373(9667): 897–910.
12.
BaguneidMMelAYildirimerL. In vivo study of a model tissue-engineered small-diameter vascular bypass graft. Biotechnol Appl Biochem2011; 58(1): 14–24.
13.
CummingsIGeorgeSKelmJ. Tissue-engineered vascular graft remodeling in a growing lamb model: expression of matrix metalloproteinases. Eur J Cardio-Thorac2012; 41: 167–172.
14.
WatersEAWicklineSA. Contrast agents for MRI. Basic Res Cardiol2008; 103: 114–121.
15.
Resch-GengerUGrabolleMCavaliere-JaricotS. Quantum dots versus organic dyes as fluorescent labels. Nature Methods2008; 5: 763–775.
16.
PissuwanDValenzuelaSMCortieMB. Prospects for gold nanorod particles in diagnostic and therapeutic applications. Biotechnol Genet Eng Rev2008; 25: 93–112.
17.
KooJH. Polymer nanocomposites: processing, characterization, and applications, New York: McGraw-Hill, 2006.
18.
TorchilinVP. Nanoparticles as drug carriers, London: Imperial College Press, 2006.
19.
GreenMO'BrienP. A simple one phase preparation of organically capped gold nanocrystals. Chem Commun2000; 3: 183–184.
20.
GreenMAllsopNWakefieldG. Trialkylphosphine oxide/amine stabilised silver nanocrystals-the importance of steric factors and Lewis basicity in capping agents. J Mater Chem2002; 12(9): 2671–2674.
21.
LuAHSalabasELSchuthF. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angewandte Chem Int Edn2007; 46(8): 1222–1244.
22.
GrabowNBüngerCMSchultzeC. A biodegradable slotted tube stent based on poly(L-lactide) and poly(4-hydroxybutyrate) for rapid balloon-expansion. Ann Biomed Eng2007; 35(12): 2031–2038.
23.
Devesi R, Misra K, Girase B, et al. Hybrid nanoscale architecture for enhancement of antimicrobial activity: immobilization of silver nanoparticles on thiol-functionalized polymer crystallized on carbon nanotubes. Adv Eng Mater (Article first published online: 21 Oct 2011 | doi: 10.1002/adem.20118008).
24.
Hofmann-AmtenbrinkMvon RechenbergBHofmannH. Nanostructured materials for biomedical applications, Kerala, India: Transworld Research Network, 2009.
25.
HussainSMBraydich-StolleLKSchrandAM. Toxicity evaluation for safe use of nanomaterials: recent achievements and technical challenges. Adv Mater2009; 21: 1–11.
26.
LewinskiNColvinVDrezekR. Cytotoxicity of nanoparticles. Small2008; 4(1): 26–49.
27.
PanYNeussSLeifertA. Size-dependent cytotoxicity of gold nanoparticles. Small2007; 3(11): 1941–1949.
28.
YenHJHsuSHTsaiCL. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small2009; 5(13): 1553–1561.
29.
DıazBSanchez-EspinelCArrueboM. Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates. Small2008; 4(11): 2025–2034.
30.
MartinDPWilliamsSF. Medical applications of poly-4-hydroxybutyrate: a strong flexible absorbable biomaterial. Biochem Eng J2003; 16: 97–105.
31.
ChenGQWuQ. The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials2005; 26: 6565–6578.
32.
SarasuaJRLópez-RodríguezNZuzaE. Crystallinity assessment and in vitro cytotoxicity of polylactide scaffolds for biomedical applications. J Mater Sci Mater Med2011; 22(11): 2513–2523.
33.
LiJXSilversteinMHiltnerA. The ductile-to-quasi-brittle transition of particulate-filled thermoplastic polyester. J Appl Polym Sci1994; 52: 255–267.
34.
KimGMLeeDHHoffmannB. Influence of nanofillers on the deformation process in layered silicate/polyamide-12 nanocomposites. Polymer2001; 42: 1095–1100.
35.
WuS. A generalized criterion for rubber toughening: The critical matrix ligament thickness. J Appl Polym Sci1988; 35: 549–563.
36.
YudinVEOtaigbeJUSvetlichnyiVM. Effects of nanofiller morphology and aspect ratio on the rheo-mechanical properties of polyimide nanocomposites. eXPRESS Polym Lett2008; 2(7): 485–493.
37.
ChichkovBNMommaCNolteS. Femtosecond, picosecond and nanosecond laser ablation of solids. Appl Phys A1996; 63(2): 109–115.
